Baidu
map

感冒发烧也找专家,因为医德和技术没有获得市场价值

2016-03-06 MedSci MedSci原创

北大口腔医院灰色的矮楼与平时看上去没什么不同,除了一条崭新的红色横幅。“严厉打击医托号贩子,维护正常诊疗秩序”,横幅上的白字毫不留情。从它下面穿过的人们匆匆走过,几乎忽略了它的存在。但只要他们进入医院大厅,就会发现这里与从前已经不同。在“女子北京看病怒斥‘号贩子’”的视频中,排了一天队的女子哭喊着指责号贩子把300元的号炒到4500元。网友们一度在这个来北京挂号的外地女孩身上看到了自己的影子。

北大口腔医院灰色的矮楼与平时看上去没什么不同,除了一条崭新的红色横幅。

“严厉打击医托号贩子,维护正常诊疗秩序”,横幅上的白字毫不留情。从它下面穿过的人们匆匆走过,几乎忽略了它的存在。但只要他们进入医院大厅,就会发现这里与从前已经不同。

在“女子北京看病怒斥‘号贩子’”的视频中,排了一天队的女子哭喊着指责号贩子把300元的号炒到4500元。网友们一度在这个来北京挂号的外地女孩身上看到了自己的影子。

有人在网上发帖:拜托哪位人大代表拟一个议案,带到今年的两会上去。“如果号贩子问题一定要等到均衡医疗资源之后才能解决,我要是号贩子,一定笑死了。”

的确有人大代表把关于号贩子的议案带到了北京。

大家都知道挂号不容易

这几天,北京各大医院的挂号大厅依然嘈杂,但却少了一群职业排队挂号的人。

此前,北京卫计委紧急出台“八条措施”打击号贩子,包括实行非急诊全面预约挂号,建立医疗机构间层级转诊网络、推出知名专家团队服务模式,市属医院内统筹调剂普通号,严格加号管理、落实实名制挂号、加强宣传引导和秩序维护、建立违规利用医院医疗资源监督举报和处罚制度等。

走在北京的地铁里,总能看见操着外地口音,神色焦虑又无助的人,手上提着写着“××”的X光片和化验单。优质卫生资源集中在北京,让全国各地的疑难杂症患者,像寻求最后的救命稻草一样,涌向这里。

在中国医学科学院医学信息研究所作的2015年度中国医院综合影响力排行榜单中,全国前100名医院排名,北京以拥有23家优质医院位居全国之首。

俞光岩在口腔医院的那栋灰色矮楼出诊时,经常拖到上午12点半才能休息。

“没办法,病人太多,大家都知道挂号不那么容易。”作为全国政协委员,俞光岩曾是北京大学口腔医学院院长。

“我们也有号贩子。”他说,医院也会对号贩子采取措施,一采取措施,倒号的现象就好一些,但总归不是长久之计。

时常呈现在医院的场景是,一排排马扎放在挂号的窗口前,号贩子们有的看书,有的打牌,牢牢把控着最有利的位置。

另一位同是医生的全国政协委员同样遇到过号贩子。北京大学第一医院心血管内科教授霍勇坦率地说,在他门诊的时候,很多人都会找他加号,有时候觉得对方好不容易来一趟也就同意了。但是,他也明白,靠加号并不能解决号贩子的问题。

“看不出找我加号的人是病人还是号贩子,有一些互联网挂号公司找到我加号,我没有答应过任何一家这样的公司。”霍勇说,“一方面,他们是不是号贩子我没有办法判断,另一方面我也没有精力加号。”

很多人感冒也要找专家

2000多公里外的广东省阳春市人民医院里,全国人大代表、妇科主任熊锦梅经历的是另一番情景。在这座县级市的医院里,并不存在号贩子。更多的,是排队找熊锦梅开转院证明的人。

“像我们广东团的钟南山院士,是解决疑难杂症的专家,但很多人感冒发烧也想找他看。”熊锦梅说。她曾遇到一进门就满脸敌意的患者,听了她的诊疗意见后,“嗖”地一下抽走病历本,扭头就走了。

“为什么人们不愿意在基层诊疗,因为病人对基层的医院信任度不够,觉得还是在大医院更加放心一点。”俞光岩说。

熊锦梅至今都还记得这种不信任导致的情绪爆发。她的同事在值夜班时遇到一家人给孩子看病,医生说吃药就能痊愈,但家属坚持打针。

这种对基层医院缺乏信心的患者和家属把希望寄托在大医院身上,加入医疗资源的争夺中。

“还是供需矛盾,找专家的患者实在太多了,很多时候,很小的病就找专家。”俞光岩说,在他印象里,他的病人中有三分之一是普通病人。他认为,问题关键在于缺少分级诊疗制度,就会导致一种现象,病人挂不上号,专家医生也很累。

医德和技术应获得相应市场价值

全国人大代表、浙江省肿瘤医院副院长葛明华在最后修改的几件建议中,有一项关于如何消除号贩子。

葛明华认为,浙江的实名制挂号制度和全省预约诊疗平台可以在全国范围内推广,基本消除“黄牛”现象。“我建议在目前实名制挂号的基础上,挂号预约系统还要加快与公安部门的身份证系统对接,并且在就诊时由医生核对病人身份信息,彻底杜绝号贩子。”葛明华说。

俞光岩提出建议,最根本的策略还是要加强对基层医务人员的培养,提高基层医务人员的专业水平。当然,还需要一些制度设计,比如尝试转诊制度与报销相挂钩。

通过筛查让很多小病在基层能治疗。霍勇说,还会有很多人想着来大医院治疗,不妨提高挂号的价格。政府要通过引导的方式,逐步解决号贩子的问题,而不能一味地靠打击号贩子来解决挂号难的问题。

他提到的分诊,在全国人大代表、腾讯公司董事会主席兼首席执行官马化腾的建议里,也出现了。

马化腾是互联网医疗的支持者,在他看来,分级诊疗与患者信息共享脱不开干系。只有让医务人员及时了解患者的诊疗、用药情况,全程跟踪病人的健康信息,提供连续的整合医疗服务,才能实现基层首诊、双向转诊、上下联动的分级诊疗体系。

打破医院的“信息孤岛”,建立并完善个人电子健康档案制度,才能实现信息的可得性和互联互通。

马化腾建议,监管部门可以建立配套政策法规,由满足要求且居民个人指定的第三方公司按照对应政策法规,在完善患者个人信息保护机制的基础上存储信息,再由居民通过互联网授权查看、使用其对应健康档案信息。

“应该进一步落实医生自由执业政策,逐步消除让医生成为‘自由人’的‘隐性障碍’,让医生的医德和技术能够获得相应的市场价值。”马化腾说。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (18)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-10 1de5aaa9m95(暂无匿称)

    期待更好的解决看病难、药费贵的政策出台

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-08 cy0327
  4. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-08 ssnine
  5. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-07 sylvia828

    马化腾又来参合个什么劲

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-07 忠诚向上

    好好学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-07 忠诚向上

    无可奈何啊

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-07 chenchuny

    拭目以待

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-07 creekf_45

    但愿医学界会越来越好

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2025727, encodeId=dcac2025e27e2, content=<a href='/topic/show?id=764c4833e1f' target=_blank style='color:#2F92EE;'>#市场价值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48337, encryptionId=764c4833e1f, topicName=市场价值)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10ba218, createdName=zgwhgch, createdTime=Sun Dec 18 16:39:00 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=68546, encodeId=5fdf6854638, content=期待更好的解决看病难、药费贵的政策出台, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a411691127, createdName=1de5aaa9m95(暂无匿称), createdTime=Thu Mar 10 22:15:00 CST 2016, time=2016-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497077, encodeId=08a6149e07719, content=<a href='/topic/show?id=d7613433511' target=_blank style='color:#2F92EE;'>#医德#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34335, encryptionId=d7613433511, topicName=医德)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e499296170, createdName=cy0327, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376874, encodeId=7a6f13e6874c0, content=<a href='/topic/show?id=ddc13e87938' target=_blank style='color:#2F92EE;'>#发烧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37879, encryptionId=ddc13e87938, topicName=发烧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25c8396, createdName=ssnine, createdTime=Tue Mar 08 13:39:00 CST 2016, time=2016-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67889, encodeId=47286e889fa, content=马化腾又来参合个什么劲, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150722/IMG55AFA86523D972628.jpg, createdBy=0e301631601, createdName=sylvia828, createdTime=Mon Mar 07 18:18:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67725, encodeId=9ca76e7256b, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:56:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67724, encodeId=2e646e7244e, content=无可奈何啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Mar 07 06:55:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67722, encodeId=f8916e722e8, content=拭目以待, beContent=null, objectType=article, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=014e108570, createdName=chenchuny, createdTime=Mon Mar 07 06:41:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67721, encodeId=caad6e721a5, content=但愿医学界会越来越好, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3001553268, createdName=creekf_45, createdTime=Mon Mar 07 06:27:00 CST 2016, time=2016-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=67646, encodeId=c4936e646bf, content=受益颇多, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b911658392, createdName=梦想天空, createdTime=Sun Mar 06 23:14:00 CST 2016, time=2016-03-06, status=1, ipAttribution=)]
    2016-03-06 梦想天空

    受益颇多

    0

相关资讯

一位医生的心声:我为什么拒谈医德

没错,我拒谈医德。我工作的这些年,经常遇到病人、家属甚至是自己的亲人抱怨医生“医德不好”,而每当我仔细听完事情的前因后果,往往发现,真正让他们耿耿于怀的其实是支付制度、医院管理和医疗技术,跟“医德”完全搭不上关系。为什么他们动辄上升到“医德”的高度,对医生的个人品质产生怀疑?正是官方长期强调“医生要有医德”的结果。在患者的眼里,到医院看病就是购买医疗专业服务,他们期求的是满意的服务过程和服务结果。

行医:请慢一点,等等自己的灵魂

印第安人有一句谚语:如果你走的太快了,要停下来,让灵魂跟上来。如果您是一名忙碌的临床医生,紧张的临床工作已经让您苦不堪言,面对目前医患关系紧张,何不慢下来,思考一下医疗这一职业。 医生要慢下来,思考 美国耶鲁医学院外科学教授许尔文.努兰左手执手术刀能拯救病人,右手执笔能写出冷冰冰医疗现场中的人性。在谈及医疗的灵魂,他说,医生与病人间有深层牵绊。医生应有同理心,持续地

做医生,就是一种信仰 !

致谢作者:北京大学第一医院肾内科副主任 周福德近几年来,医闹、伤医、对簿公堂现象时有发生,频繁出现的伤医事件,再加上频繁曝光的葛兰素史克中国公司、赛诺菲公司等涉及医药领域的商业贿赂案件更加伤害了患者对医生的信任,不利于改善医患关系。 最近一些时间,全国连续发生很多起伤医事件,再次突显当前国内的医患关系紧张氛围。这是对中国六百多万医生的严峻考验。少数医生已经放弃这个高尚职业;大多数

我没有医德

最近很倒霉,继上次夜班被黑社会威胁殴打之后,昨日夜班又遭遇被“强奸犯”。可怜我清白的名誉。夜班独自来了一位50岁左右大妈,糖尿病、双下肢水肿、右下肢局部红肿热痛。大妈要求皮下注射胰岛素消肿。我告诉她胰岛素只能控制血糖,对于水肿没有什么什么效果,更不会立竿见影,而且右下肢有感染迹象,最好住院治疗。大妈说你凭什么不给打胰岛素,白求恩在中国救了几万人,你们见死不救,没有医德。大妈又语无伦次的说自己的

Baidu
map
Baidu
map
Baidu
map